Atlas Trials

Relapsed and/or Refractory Multiple Myeloma

24 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed and/or Refractory Multiple Myeloma

RecordFirmDate
Retrospective Study of the Use of Belantamab Mafodotin (Blenrep®) in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) in Spain. (NCT05297240)PETHEMA Foundation2022-03-24
A Study to Access the Safety and Efficacy of CT0590 in Patients With Relapsed and/or Refractory Multiple Myeloma (NCT05066022)The First Affiliated Hospital of Soochow University2021-10-28
A Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous TAK-573 as Part of Combination Therapy in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) (NCT04392648)Teva Branded Pharmaceutical Products R&D LLC2020-06-24
A Study of MT-0169 in Participants With Relapsed or Refractory Multiple Myeloma (NCT04017130)Molecular Templates, Inc.2020-02-05
Quality of Life, Symptoms and Treatment Satisfaction in Adult Patients With Relapsed and/or Refractory Multiple Myeloma, Receiving Ixazomib (Ninlaro®) in Combination With Lenalidomide and Dexamethasone in a Real World Setting: Pilot Study (NCT03903406)Multinational Center for Quality of Life Research, Russia2019-05-01
Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex (NCT03715478)Canadian Myeloma Research Group2018-11-26
A Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated With Ixazomib Plus Lenalidomide and Dexamethasone (NCT03433001)Takeda2018-04-02
A Study to Evaluate the Efficacy and Safety of Ixazomib in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Initially Treated With an Injection of Proteasome Inhibitor-Based Therapy (NCT03416374)Takeda2018-02-18
Carfilzomib Thalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma (NCT03140943)National University Hospital, Singapore2017-09-13
A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma (NCT03170882)Millennium Pharmaceuticals, Inc.2017-08-01
A Study of Ixazomib Plus Lenalidomide and Dexamethasone in Adult Japanese Participants With Relapsed and/or Refractory Multiple Myeloma (NCT02917941)Takeda2016-11-01
A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma (NCT02831686)Memorial Sloan Kettering Cancer Center2016-07-01
The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-ineligible Patients With Relapsed and/or Refractory Multiple Myeloma (MM) (NCT03242460)Kosin University Gospel Hospital2015-05-12
A Study of MLN9708 in Japanese Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) (NCT04272775)Takeda2012-06-05
Safety Study of Elotuzumab in Combination With Thalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma (NCT01632150)Bristol-Myers Squibb2012-05-01
Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma (NCT00882063)Piramal Enterprises Limited2008-01-01
Expanded Access Program for Melphalan Flufenamide (Melflufen) in Triple Class Refractory Multiple Myeloma (NCT04534322)Oncopeptides AB

Track Relapsed and/or Refractory Multiple Myeloma automatically

Every clearance here is in the API, with alerts when new ones post.